Intervention not reported
Vascular mortality (ticlopidine vs placebo) · patients with type 2 diabetes mellitus
The intervention showed no clear difference in vascular mortality (ticlopidine vs placebo) (moderate certainty).
1 finding from 1 review
- Adenosine‐diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes… 2012 · Cochrane Headline outcomes onlyRR 0.94 [0.47, 1.88]1 study · 335 participantsModerate